To routinely offer testing for HIV infection in all cases of tuberculosis: A rational clinical approach?

Medical Journal of Australia

Volumn 188, Issue 3, 2008, Pages 162-163

  Emerson, Carol R ^a,b   Post, Jeffrey J ^a,b,c  

^a PRINCE OF WALES HOSPITAL   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; AUSTRALIA; EPIDEMIC; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; MYCOBACTERIUM TUBERCULOSIS; RELIABILITY; RISK ASSESSMENT; SCREENING TEST; TUBERCULOSIS; HUMAN; LUNG TUBERCULOSIS; MASS SCREENING; PREVALENCE;

AUSTRALIA; HIV INFECTIONS; HUMANS; MASS SCREENING; PREVALENCE; TUBERCULOSIS, PULMONARY;

EID: 42449138851     PISSN: 0025729X     EISSN: 13265377     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2008.tb01562.x     Document Type: Article

References (28)

1. Post JJ. Mycobacterium tuberculosis. In: Hoy J, Lewis S, editors. HIV management in Australia, a guide for clinical care. Sydney: Australian Society for HIV Medicine, 2003.
2. Valway SE, Richards SB, Kovacovich J, et al. Outbreak of multi-drug-resistant tuberculosis in a New York State prison. Am J Epidemiol 1994; 140: 113-122.
3. Selwyn PA, Hartel D, Lewis VA, et al. A prospective study of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med 1989; 320: 545-550.
4. Small PM, Shafer RW, Hopewell PC, et al. Exogenous reinfection with multidrug-resistant Mycobacterium tuberculosis in patients with advanced HIV infection. N Engl J Med 1993; 328: 1137-1144.
5. Onorato IM, McCray E. Prevalence of human immunodeficiency virus infection among patients attending tuberculosis clinics in the United States. J Infect Dis 1992; 165: 87-92.
6. Whalen C, Horsburgh CR, Hom D, et al. Accelerated course of human immunodeficiency virus infection after tuberculosis. Am J Respir Crit Care Med 1995; 151: 129-135.
7. Collins KR, Quinones-Mateu ME, Toossi Z, et al. Impact of tuberculosis on HIV-1 replication, diversity, and disease progression. AIDS Rev 2002; 4: 165-176.
8. Goletti D, Weissman D, Jackson RW, et al. Effect of Mycobacterium tuberculosis on HIV replication. Role of immune activation. J Immunol 1996; 157: 1271-1278.
9. Corbett EL, Watt CJ, Walker N, et al. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med 2003; 163: 1009-1021.
10. Workman C. Clinical manifestations of HIV disease. In: Hoy J, Lewis S, editors. HIV management in Australia, a guide for clinical care. Sydney: Australian Society for HIV Medicine, 2003.
11. Roche PW, Bastian I, Krause V. Tuberculosis notifications in Australia, 2005. Commun Dis Intell 2007; 31: 71-80.
12. Heath TC, Roberts C, Winks M, et al. The epidemiology of tuberculosis in New South Wales 1975-1995. Int J Tuberc Lung Dis 1998; 2: 647-654.
13. Wark P, Goldberg H, Ferson M, et al. Mycobacterial lymphadenitis in eastern Sydney. Aust N Z J Med 1998; 28: 453-458.
14. Dore GJ, Yueming L, McDonald A, et al. Impact of highly active antiretroviral therapy on individual AIDS-defining illness incidence and survival in Australia. J Acquir Immune Defic Syndr 2002; 29: 388-395.
15. National Centre in HIV Epidemiology and Clinical Research. HIV/AIDS, viral hepatitis and sexually transmissible infections in Australia Annual Surveillance Report 2006. Sydney: National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, 2006. http://www.nchecr.unsw.edu.au/NCHECRweb.nsf/page/ Annual%20Surveillance%20Reports (accessed Oct 2007).
16. Australian Government Department of Health and Ageing. National HIV Testing Policy 2006. Canberra: Department of Health and Ageing, 2006. http://www.health.gov.au/internet/wcms/publishing.nsf/Content/ healthpubhlth-strateg-hiv_hepc-hiv-index.htm (accessed Oct 2007).
17. Communicable Diseases Network Australia. National Strategic Plan for TB Control in Australia Beyond 2000. Canberra: Department of Health and Ageing, 2002. http://www.health.gov.au/internet/wcms/Publishing.nsf/ Content/cda-pubs-other-tb_plan.htm (accessed Oct 2007).
18. NSW Health. Tuberculosis and HIV. Policy directive PD2005_076. http://www.health.nsw.gov.au/policies/PD/2005/pdf/PD2005_076.pdf (accessed Oct 2007).
19. Victorian Government Department of Human Services. Management, control and prevention of tuberculosis. Guidelines for health care providers (2002-2005). Melbourne: Department of Human Services, 2002. http://www.health.vic.gov.au/_data/assets/pdf_file/0006/19986/ tb_mgmt_guide.pdf (accessed Oct 2007).
20. Houston S, Schwartzman, Brassard P, et al. Tuberculosis and human immunodeficiency virus. In: Long R, Chernick V, Elwood K, et al, editors. The Canadian tuberculosis standards. 5th ed. Ottawa: Health Canada and the Canadian Lung Association, 2000: 45-65. http://www.phacaspc.gc.ca/publicat/cts-ncla00/index.html (accessed Oct 2007).
21. Iskander R, Wass T, Jones J, et al. Communicable Diseases Surveillance Centre annual report 2001. London: London Regional Office, 2001.
22. American Thoracic Society, CDC, and Infectious Diseases Society of America. Treatment of tuberculosis. MMWR Recomm Rep 2003; 52(RR-11): 1-77.
23. Ministry of Health, New Zealand. Guidelines for tuberculosis control in New Zealand 2003. Wellington: Ministry of Health, 2002. http://www.moh.govt.nz/publications/guidelines (accessed May 2007).
24. Barnes P, Silva C, Otaya M. Testing for human immunodeficiency virus infection in patients with tuberculosis. Am J Respir Crit Care Med 1996; 153: 1448-1450.
25. Geduld J, Brassard P, Culman K, et al. Testing for HIV among patients with tuberculosis in Montreal. Clin Invest Med 1999; 22: 111-118.
26. Paltiel AD, Walensky RP, Schackman BR, et al. Expanded HIV screening in the United States: effect on clinical outcomes, HIV transmission and costs. Ann Intern Med 2006; 145: 797-806.
27. BT v Oei [1999] NSWSC 1082.
28. Palella FJ Jr, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV outpatient study investigators. N Engl J Med 1998; 338: 853-860.